Fulcrum Therapeutics
FULC
#6246
Rank
A$1.28 B
Marketcap
A$19.47
Share price
1.41%
Change (1 day)
191.11%
Change (1 year)

Fulcrum Therapeutics (FULC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$24.73 Million

According to Fulcrum Therapeutics's latest financial reports the company's total liabilities are A$24.73 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Fulcrum Therapeutics - Total liabilities on balance sheet (from 2018 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$28.43 M-13.92%
2023-12-31A$33.02 M-18.99%
2022-12-31A$40.76 M25.98%
2021-12-31A$32.36 M-27.66%
2020-12-31A$44.73 M34.5%
2019-12-31A$33.25 M139.79%
2018-12-31A$13.86 M258.79%
2017-12-31A$3.86 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ORIC Pharmaceuticals
ORIC
A$36.41 M 47.18%๐Ÿ‡บ๐Ÿ‡ธ USA